150 related articles for article (PubMed ID: 6265385)
21. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
[TBL] [Abstract][Full Text] [Related]
22. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
Reedman BM; Hilgers J; Hilgers F; Klein G
Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-associated antibody pattern in untreated non-Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions.
Lindemalm C; Biberfeld P; Björkholm M; Henle G; Henle W; Holm G; Johansson B; Klein G; Mellstedt H
Int J Cancer; 1983 Dec; 32(6):675-82. PubMed ID: 6317577
[TBL] [Abstract][Full Text] [Related]
24. Malignant lymphoma induction of rabbits with oral spray of Epstein-Barr virus-related herpesvirus from Si-IIA cells (HTLV-II-transformed Cynomolgus cell line): a possible animal model for Epstein-Barr virus infection and subsequent virus-related tumors in humans.
Koirala TR; Hayashi K; Chen HL; Ino H; Kariya N; Yanai H; Choudhury CR; Akagi T
Pathol Int; 1997 Jul; 47(7):442-8. PubMed ID: 9234382
[TBL] [Abstract][Full Text] [Related]
25. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line,
Dalianis T; Klein G; Andersson B
Int J Cancer; 1977 Apr; 19(4):460-7. PubMed ID: 191413
[TBL] [Abstract][Full Text] [Related]
26. EB virus: malignant lymphoma in cottontop marmosets following inoculation and recovery of the virus from cells of an experimental tumor maintained in organ culture.
Shope TC; Miller G
Bibl Haematol; 1975; (40):375-83. PubMed ID: 169816
[TBL] [Abstract][Full Text] [Related]
27. Evolution of infectious mononucleosis into Epstein-Barr virus carrying monoclonal malignant lymphoma.
Abo W; Takada K; Kamada M; Imamura M; Motoya T; Iwanga M; Aya T; Yano S; Nakao T; Osato T
Lancet; 1982 Jun; 1(8284):1272-6. PubMed ID: 6123020
[TBL] [Abstract][Full Text] [Related]
28. Seroconversion against Epstein-Barr virus in two nonhuman primate species infected by the oropharyngeal route.
Glaser R; Lee KJ; Lang CM; Levy B
J Infect Dis; 1978 Nov; 138(5):695-8. PubMed ID: 213505
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
Henle G; Henle W
Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
[TBL] [Abstract][Full Text] [Related]
30. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma.
Sutherland JC; Olweny CL; Levine PH; Mardiney MR
J Natl Cancer Inst; 1978 May; 60(5):941-6. PubMed ID: 205665
[No Abstract] [Full Text] [Related]
32. Humoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients.
Biggar RJ; Pandey JP; Henle W; Nkrumah FK; Levine PH
Int J Cancer; 1984 May; 33(5):577-80. PubMed ID: 6327537
[TBL] [Abstract][Full Text] [Related]
33. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
[TBL] [Abstract][Full Text] [Related]
34. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
35. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups.
Lin TM; Yang CS; Chiou JF; Tu SM; Chen TY; Tu YC; Lin PJ; Kawamura A; Hirayama T
Am J Epidemiol; 1977 Oct; 106(4):336-9. PubMed ID: 199059
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNA.
Szigeti R; Saemundsen AK; Synnerholm AC; Henle G; Henle W; Klein G
Cancer Res; 1983 May; 43(5):2273-6. PubMed ID: 6299543
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of EBV-infected cells in HIV-related lymphadenopathy: implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals.
Dolcetti R; Gloghini A; De Vita S; Vaccher E; De Re V; Tirelli U; Carbone A; Boiocchi M
Int J Cancer; 1995 Nov; 63(5):652-9. PubMed ID: 7591281
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to Epstein-Barr viral capsid and early antigens associated with Burkitt's lymphoma and lymphoblastic lymphosarcoma in Israel.
Gotleib-Stematsky T; Ramot B; Vonsover B; Aghai E; Kende G; Ninio M; Modan M
J Natl Cancer Inst; 1976 Apr; 56(4):721-3. PubMed ID: 233958
[TBL] [Abstract][Full Text] [Related]
39. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.
Sairenji T; Hinuma Y
Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005
[TBL] [Abstract][Full Text] [Related]
40. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
